Ceftazidime Dosing in Hemodialysis Patients

For a hemodialysis patient with minimal renal function, order ceftazidime 1 gram IV after each dialysis session 1.

Dosing Regimen

Administer 1 gram IV immediately after each hemodialysis session 1
This dosing applies to patients on a typical thrice-weekly hemodialysis schedule 1
The timing is critical: give the dose after dialysis to prevent premature drug removal and facilitate directly observed therapy 1

In your specific scenario where the patient missed dialysis for a month, the approach depends on current renal function:

If truly anuric (no urine output): Give an initial loading dose of 1 gram IV, then adjust based on when dialysis resumes 2, 3
If some residual renal function exists (creatinine clearance <30 mL/min): Give 1 gram every 24-48 hours until dialysis is re-established 2
Once dialysis resumes: Return to the standard 1 gram post-dialysis dosing 1

Ceftazidime is 80-90% renally excreted and significantly removed by hemodialysis (approximately 55% of the dose) 3, 4
The elimination half-life extends from 1.9 hours in normal renal function to approximately 25-34 hours in anuric patients 3, 4
A 4-hour hemodialysis session reduces ceftazidime concentrations by approximately 88% 3, 4
Post-dialysis dosing of 1 gram achieves reliable pharmacodynamic target attainment (>70% time above MIC) for organisms with MIC ≤8 mg/L over 48-hour interdialytic intervals 5, 6

2 grams post-dialysis may be considered for 72-hour interdialytic intervals or for organisms with MIC ≤8 mg/L, but is generally unnecessary for standard 48-hour intervals 5, 6
The 2-gram dose was equally effective and well-tolerated in studies but may not provide additional benefit for most clinical scenarios 5

This is the most important complication to monitor in patients with renal impairment:

Elevated ceftazidime levels can cause seizures, non-convulsive status epilepticus, encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia 2, 7
A neurotoxicity threshold of 78 mg/L has been proposed based on case series 7
Ceftazidime has moderate pro-convulsive activity (17% relative to penicillin G = 100%) 1
Never give full doses (e.g., 1-2 grams every 8 hours) to patients with severe renal impairment without dialysis 2

Monitor for neurological symptoms including altered mental status, myoclonus, or seizures 2, 7
If neurotoxicity occurs, discontinue ceftazidime immediately—symptoms typically improve within days 7
Consider therapeutic drug monitoring if available, especially in patients with unpredictable dialysis schedules 6

For patients requiring more frequent dosing between dialysis sessions:

500 mg to 1 gram once daily (regardless of dialysis schedule) achieves adequate target attainment for organisms with MIC ≤16-32 mg/L 6
This approach may be preferable for critically ill patients or more resistant organisms 6

For catheter-related bloodstream infections:

Ceftazidime can be used as an antibiotic lock solution at 0.5 mg/mL concentration with 100 IU/mL heparin 1
This is adjunctive to systemic therapy, not a replacement 1

Do not reduce the individual dose—instead, increase the dosing interval 1, 2. Smaller doses reduce efficacy due to ceftazidime's concentration-dependent bactericidal activity 1
Do not give ceftazidime before dialysis—this results in significant drug loss and suboptimal concentrations 1, 3
Do not use standard dosing (1-2 grams every 8 hours) in patients with severe renal impairment—this leads to dangerous drug accumulation and neurotoxicity 2, 7
Do not assume all dialysis modalities are equivalent—high-flux hemodialysis removes more drug than low-flux dialysis 6
Avoid intra-arterial administration—this can cause distal necrosis 2